Pharmaceutical Biotechnology 24 months Postgraduate Programme By University of Milan |TopUniversities
Subject Ranking

# =49QS Subject Rankings

Programme Duration

24 monthsProgramme duration

Tuitionfee

156 EURTuition Fee/year

Main Subject Area

Pharmacy and PharmacologyMain Subject Area

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

MSc

Study Level

Masters

Study Mode

On Campus

The master degree program in Pharmaceutical Biotechnology aims to prepare graduates who have advanced skills in the development and application of new scientific methodologies, who are able to actively participate in national and international study and research projects, and who possess in-depth skills in the scientific and technical-productive aspects of biotechnology applied to human health with particular reference to the design and engineering of innovative biotechnological drugs. The master degree program in Pharmaceutical Biotechnology is structured into four curricula. A first curriculum is aimed at providing in-depth skills in the scientific aspects of biotechnological drug design and design, characterization of their molecular and cellular mechanisms and therapeutic potential. A second curriculum provides in-depth knowledge of biotechnology drug development and production and provides notions for the organization and management of biotechnology enterprises. A third curriculum develops aspects related to the use of biotechnology drugs in precision therapy, starting from the physio-pathological context, strategy and design to manufacturing and formulation. The three curricula include common specialized teachings (first semester of the first year), which are necessary to broaden and deepen the basic skills acquired during the undergraduate degree, and characterizing teachings aimed at deepening the specificities of the curriculum, which are separated starting from the second semester of the first year and in the first semester of the second year. A fourth curriculum provides preparation for future challenges in the field of the most innovative biotechnology drugs. In particular, this curriculum includes teachings in common biotechnology and pharmaceutical disciplines, which are necessary to expand the basic skills acquired during the undergraduate degree, and specialized teachings that include omics approaches, molecular modeling, biomarkers, cell therapies, nanotechnologies and pharmacogenomics. For all curricula, the second semester of the second year is devoted to conducting the internship at facilities of the University or other public or private institutions or companies.

Master degree graduates in Pharmaceutical Biotechnology have the skills to manage biotechnological, pharmaceutical and pharmacological laboratories with an high level of autonomy, assuming the responsibility of projects and units; to promote and develop scientific and technological innovation in the field of pharmaceutical biotechnology; to manage biotechnological, chemical and pharmaceutical productive plants; to contribute or even organize development and monitoring plans of biotechnologies (also at management and administrative level) taking care of the ethical, technical, legal, and environmental protection implications.

Programme overview

Main Subject

Pharmacy and Pharmacology

Degree

MSc

Study Level

Masters

Study Mode

On Campus

The master degree program in Pharmaceutical Biotechnology aims to prepare graduates who have advanced skills in the development and application of new scientific methodologies, who are able to actively participate in national and international study and research projects, and who possess in-depth skills in the scientific and technical-productive aspects of biotechnology applied to human health with particular reference to the design and engineering of innovative biotechnological drugs. The master degree program in Pharmaceutical Biotechnology is structured into four curricula. A first curriculum is aimed at providing in-depth skills in the scientific aspects of biotechnological drug design and design, characterization of their molecular and cellular mechanisms and therapeutic potential. A second curriculum provides in-depth knowledge of biotechnology drug development and production and provides notions for the organization and management of biotechnology enterprises. A third curriculum develops aspects related to the use of biotechnology drugs in precision therapy, starting from the physio-pathological context, strategy and design to manufacturing and formulation. The three curricula include common specialized teachings (first semester of the first year), which are necessary to broaden and deepen the basic skills acquired during the undergraduate degree, and characterizing teachings aimed at deepening the specificities of the curriculum, which are separated starting from the second semester of the first year and in the first semester of the second year. A fourth curriculum provides preparation for future challenges in the field of the most innovative biotechnology drugs. In particular, this curriculum includes teachings in common biotechnology and pharmaceutical disciplines, which are necessary to expand the basic skills acquired during the undergraduate degree, and specialized teachings that include omics approaches, molecular modeling, biomarkers, cell therapies, nanotechnologies and pharmacogenomics. For all curricula, the second semester of the second year is devoted to conducting the internship at facilities of the University or other public or private institutions or companies.

Master degree graduates in Pharmaceutical Biotechnology have the skills to manage biotechnological, pharmaceutical and pharmacological laboratories with an high level of autonomy, assuming the responsibility of projects and units; to promote and develop scientific and technological innovation in the field of pharmaceutical biotechnology; to manage biotechnological, chemical and pharmaceutical productive plants; to contribute or even organize development and monitoring plans of biotechnologies (also at management and administrative level) taking care of the ethical, technical, legal, and environmental protection implications.

Admission Requirements

72+
5.5+
Admission requirements The following candidates are eligible for the Master's degree programme in Pharmaceutical Biotechnology: - Graduates of class L-2, as well as the corresponding classes pursuant to Ministerial Decree 509/99; - Graduates of other classes, provided they meet the following requirements: - at least 9 academic credits (CFU) across the following subject areas (SSD): CHIM/01, CHIM/03 and/or CHIM/06; - at least 12 academic credits (CFU) across the following subject areas (SSD): BIO/10, BIO/11 and/or BIO/13; - at least 6 academic credits (CFU) in the following subject area: (SSD): BIO/14; - at least 6 academic credits (CFU) across the following subject areas (SSD): BIO/09, BIO/16 and/or MED/04; - Holders of a qualification obtained abroad and recognized as suitable who prove that they have acquired the same level of knowledge and skills in biology, chemistry, biochemistry, molecular biology, pharmacology, anatomy, pathology and physiology, as specified above.
Admission assessment In addition to curricular requirements, admission to the programme is subject to an assessment test. Curricular requirements will be assessed by an admissions board appointed by the Academic Board and composed of at least three faculty members supported by the teaching secretariat, based on the candidate's previous academic records, and possibly an interview. The curricular assessment will ascertain the level of knowledge (credits earned and grade achieved) in the following subjects: general and inorganic chemistry (CHIM/03), analytical chemistry (CHIM/01) and organic chemistry (CHIM/06); biochemistry (BIO/10), molecular biology (BIO/11) and biology (BIO/13); pharmacology (BIO/14); anatomy (BIO/16), physiology (BIO/09) and pathology (MED/04). Please note that the knowledge of the aforementioned disciplines may also have been achieved by attending single courses. The interview, if any, may be held in person (in the classrooms of the Department of Pharmacological and Biomolecular Sciences, Via Balzaretti 9, Milan) or online. Upcoming graduates are also eligible for the interview. The dates, time and place of in-person interviews will be posted to the degree programme website: https://biotecnologiafarmaco.cdl.unimi.it/en The interview dates will be agreed by e-mail with individual candidates.
Language skills Proficiency in English at a B2 level or higher per the Common European Framework of Reference for Languages (CEFR) is required for admission.

2 Years
Oct

Tuition fees

Domestic
0 EUR
International
156 EUR

Scholarships

Selecting the right scholarship can be a daunting process. With countless options available, students often find themselves overwhelmed and confused. The decision can be especially stressful for those facing financial constraints or pursuing specific academic or career goals.

To help students navigate this challenging process, we recommend the following articles:

More programmes from the university

Postgrad Programmes 1873